Document Type

Thesis

Date of Degree Completion

Spring 2007

Degree Name

Bachelor of Science

Department

Chemistry

Committee Chair

Dr. Levente Fabry-Astalos, Department of Chemistry

Second Committee Member

Dr. Andrew A. Piacsek, Science Honors Research Program Director

Abstract

Although current HIV-1 protease inhibitors on the market show high specificity, a number of side effects can result from their administration. Furthermore, quick drug resistance is developed due to mutations of the protease. Consequently, there exists a great and urgent need for the development of a novel HIV-1 protease inhibitors that have less toxicity, greater bioavailability, and exhibit distinct resistance profiles. Recent studies have shown that borinic acid HIV-1 protease inhibitors, which can act both associatively and competitively, have a higher affinity for HIV-1 protease variants than compounds that are strictly transition state analogs. Furthermore, such inhibitors were found to be potent at lower concentrations than non-boronated protease inhibitors. The steps taken toward the synthesis of three novel potential borinic acid HIV-1 protease inhibitors are described.

Comments

This thesis has been digitized and made available as part of the University’s ongoing preservation and access initiatives. Copyright is retained by the original author. The University has made a good faith effort to review this work for copyright and privacy concerns prior to digitization. If you are the author or a rights holder and have questions, concerns or wish to request removal, please contact ScholarWorks@cwu.edu.

Included in

Chemistry Commons

Share

COinS